単一ミトコンドリアATPプロフィーリングは,がんにおける標的型OXPHOS依存性の発見を導く
Xu Xiao1, Cheng Lu1, Hao Chen1
1Department of Chemical Biology, MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Fujian Key Laboratory of Chemical Biology (Xiamen University), State Key Laboratory of Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, Fujian, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 13, 2026
まとめ
癌細胞は正常細胞よりもミトコンドリアのATPレベルが高く,これは新しいナノフロー細胞測定法によって明らかになった. このプラットフォームは,ミトコンドリア代謝阻害剤をスクリーニングすることにより,標的治療の開発に役立ちます.
科学分野:
- バイオケミストリー バイオケミストリー
- 細胞生物学 細胞生物学
- がん研究 がん研究
背景:
- mitochondrial adenosine triphosphate (mitoATP) は癌細胞のエネルギーに不可欠ですが,その測定は困難です.
- がん細胞は,ウォーブルク効果とは対照的に,酸化性リン酸化 (OXPHOS) に依存することが多い.
- ミトコンドリアの異質性と細胞干渉は,臓器レベルでのATP定量化を複雑にします.
研究 の 目的:
- シングルミトコンドリアATP測定のための新しいプラットフォームを開発する.
- がん細胞におけるミトATPレベルを,正常細胞と比較して定量化するために.
- がん選択性ミトコンドリア代謝阻害剤のスクリーニング戦略を確立する.
主な方法:
- シングルミトコンドリアATP測定のためのナノフローサイトメトリプラットフォームであるMitoATP-nFCMを開発しました.
- 同時に光と横の散乱の検出を活用した.
- ATPレベル,膜ポテンシャル,ATP合成酵素,ヘキソキナーゼ2を分析し,抑制剤をスクリーニングした.
主要な成果:
- MitoATP-nFCMにより,単一オルガネルATPの正確な定量化が可能になりました.
- がん細胞のミトコンドリアは,正常細胞よりも1.7-1.9倍高いATPレベルを示した.
- 特定された特定のOXPHOS阻害剤:ベダキリン,VLX600,およびCPI-613.
結論:
- MitoATP-nFCMは,がんにおけるミトコンドリアのバイオエナジェティクスをプロファイリングするための貴重なツールです.
- 癌細胞は,リプログラムされたミトコンドリア代謝を持つOXPHOS支配的なフェノタイプを示します.
- このプラットフォームは,がん治療のための新型ミトコンドリア代謝阻害剤の精密なスクリーニングを容易にする.
関連する概念動画
ATP Yield
79.2K
Cellular respiration produces 30 - 32 ATP per glucose molecule. Although most of the ATP results from oxidative phosphorylation and the electron transport chain (ETC), 4 ATP are gained beforehand (2 from glycolysis and 2 from the citric acid cycle).
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
79.2K
Hydrolysis of ATP
82.0K
The bonds of adenosine triphosphate (ATP) can be broken through the addition of water, releasing one or two phosphate groups in an exergonic process called hydrolysis. This reaction liberates the energy in the bonds for use in the cell—for instance, to synthesize proteins from amino acids.
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine...
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine...
82.0K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Drug Discovery: Overview
11.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.9K
ATP Synthase: Mechanism
17.3K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
17.3K
ATP and Energy Production
2.0K
Adenosine triphosphate (ATP) is a critical molecule that functions as the main energy carrier in cells. Structurally, ATP consists of an adenosine molecule—comprising adenine and ribose—bonded to three phosphate groups. The high-energy bonds between these phosphate groups store significant amounts of potential energy. This energy is released during hydrolysis, wherein ATP is converted to adenosine diphosphate (ADP) or adenosine monophosphate (AMP), driving a variety of essential...
2.0K


